REQUEST A DEMO
Total
USD $0.00
Search more companies

Amedart OOO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Amedart OOO Profile Updated: August 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Amedart OOO is a company in Russia, with a head office in Moscow. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on December 04, 2009. In 2023, the company reported a net sales revenue increase of 157.66%. Its’ total assets recorded a growth of 52.56%. The net profit margin of Amedart OOO increased by 5.28% in 2023.

Headquarters
Volgogradskii, 42, 24, 2 Komnata 11.1
Moscow; Moscow; Postal Code: 109316

Contact Details: Purchase the Amedart OOO report to view the information.

Website: http://inmedtrade.ru

Basic Information
Outstanding Shares:
Purchase the Amedart OOO report to view the information.
Registered Capital:
Purchase the Amedart OOO report to view the information.
Incorporation Date:
December 04, 2009
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Medica-N OOO
20%
Company Performance
Financial values in the chart are available after Amedart OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
157.66%
Total operating revenue
157.66%
Operating profit (EBIT)
186.73%
Net Profit (Loss) for the Period
182.76%
Total assets
52.56%
Total equity
248.94%
Operating Profit Margin (ROS)
7.22%
Net Profit Margin
5.28%
Return on Equity (ROE)
-16.74%
Debt to Equity Ratio
-234.47%
Quick Ratio
-1.41%
Cash Ratio
-2.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?